Indian Journal of Innovative Clinical Research adheres to the International Open Access Publishing standards, upholding the Principles of Transparency and Best Practices in all publishing activities. This includes clear guidelines for retracting articles, editorial conduct, peer review processes, and author responsibilities.

Principles of Transparency:

• Peer Review Process: All submissions undergo rigorous peer review by external experts and editorial board members.
• Governing Body: Editorial board members' names and affiliations are transparently displayed on the journal’s website.
• Editorial Contact: Details of the editorial team, including contact information, are readily available online.
• Author Fees: Information on publication fees is clearly provided on the journal’s website. For more details, visit the Article Processing Charges
• Copyright: Copyright and licensing details are specified on the website and all published articles, available in both HTML and PDF formats, adhere to the Creative Commons Attribution License 4.0.

Research Misconduct: Indian Journal of Innovative Clinical Research takes allegations of research misconduct seriously. The journal is committed to identifying and preventing the publication of work involving misconduct, such as plagiarism, data falsification, or citation manipulation. If such issues arise, they are addressed following the guidelines of International Open Access Publishing.

Ownership and Management: Clear information about the journal's ownership and management is provided to avoid misleading authors and editors.

Web Presence:  Journal website maintain accuracy and transparency, avoiding any misleading information.

Conflicts of Interest: Policies on handling conflicts of interest for editors, authors, and reviewers are clearly stated on the website.

Access: Journal is open access, allowing free and unrestricted access to all published content.

Advertising: The journal offers free advertising for universities or institutes related to the journal’s scope, benefiting the readership.

Publishing Schedule: The publication frequency is clearly mentioned on each journal's webpage.

Archiving: The journals have a robust plan for electronic backup and preservation of content, ensuring continuous access through platforms like Academia.edu and Scribd.com.

Direct Marketing: Journal employs targeted and appropriate direct marketing activities, including the solicitation of manuscripts.

Author Guidelines

Authors are expected to follow the standard guidelines provided by Indian Journal of Innovative Clinical Research. This includes ensuring accuracy and correct formatting of references. Authors are encouraged to suggest reviewers to expedite the peer-review process.

Peer-Review Process

Submissions to Indian Journal of Innovative Clinical Research undergo a stringent double-blind peer-review process, with the final decision made by the assigned Editor. Accepted articles are thoroughly proofed and published with the authors' approval.

Terms & Conditions

• Submissions must be original and unpublished.
• Authors must not submit their work to multiple journals simultaneously.
• It is the authors' responsibility to obtain necessary permissions and provide supporting documents.
• Authors retain copyrights of their published work.
• Authors agree to reproduce any copyrighted material.

Editor Guidelines

Indian Journal of Innovative Clinical Research, established in 2024, supports researchers by publishing innovative ideas on an open-access platform, without considering publication fees. Each manuscript is subject to a double-blind peer-review process, with the Editor-in-Chief responsible for the journal's scientific quality.

Guidelines for Reviewers

Reviewers for Indian Journal of Innovative Clinical Research are crucial in maintaining the quality of published work. They follow a double-blind review process and are encouraged to provide clear recommendations on manuscript acceptance, revision, or rejection. Reviewers are expected to disclose any conflicts of interest and to report any ethical concerns immediately.